A smarter insulin that aims for the liver could curb dangerous nighttime dips
Disease control
Completed
This trial tests whether a specially designed mealtime insulin, HDV-insulin lispro, can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use continuous glucose monitors and work with doctors to adjust doses. One group receives the …
Phase: PHASE2 • Sponsor: Diasome Pharmaceuticals • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC